Article Excerpt: A multi-year clinical trial at the University of Texas Medical Branch (UTMB) and Medical University of South Carolina (MUSC) will examine the use of a wearable device thought to stimulate nerves near the ear to change signals in the brain as a treatment for chronic pain and opioid tapering. The trial, known as tANdem, is being funded by an $8.8 million grant from the National Institutes of Health National Institute of Neurological Disorders and Stroke, and is designed to provide an understanding of the mechanistic, neurophysiological and antinociceptive effects of transcutaneous auricular neurostimulation (tAN), which has been shown to reduce pain and the symptoms of withdrawal.
Full Article: https://tinyurl.com/4d266t22
Article Source: Investors Observer